Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the first quarter fiscal year 2015 ended July 31, 2014.
Help employers find you! Check out all the jobs and post your resume.